Endocrinology, Diabetes & Metabolism Doctors in Lafayette, CO Accepting Medicare

3 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 3

Dr. Jill S Maaske, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. Laura P Wolsko, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

Dr. David J Depaolo, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545

News Archive

Alcohol-related cirrhosis mortality on the rise among young adults

Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

Devon Medical Products gets FDA marketing approval for extriCARE 3600 NPWT pump and foam kit

Global medical device designer and manufacturer Devon Medical Products today announced substantial additions to its Negative Pressure Wound Therapy (NPWT) wound care product line after receiving Food & Drug Administration 510(k) clearance to market its extriCARE 3600 NPWT pump and foam dressing kit.

Many children incorrectly restrained in cars

Car accidents are the main cause of serious injury and death among children in Norway. A new study from the Norwegian Institute of Public Health shows that 37 per cent of all children under 16 years are incorrectly restrained in the car. 23 per cent of children are so poorly restrained that a collision would have very serious consequences. The study results were presented at a seminar on traffic accidents in Oslo on 8th October.

Combination of ipilimumab and nivolumab drugs reduces tumor size in metastatic melanoma patients

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).

Read more Medical News

› Verified 9 days ago